403 related articles for article (PubMed ID: 25174930)
1. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
[TBL] [Abstract][Full Text] [Related]
2. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
3. Progress in antiretroviral drug delivery using nanotechnology.
Mallipeddi R; Rohan LC
Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
[TBL] [Abstract][Full Text] [Related]
4. Long-acting slow effective release antiretroviral therapy.
Edagwa B; McMillan J; Sillman B; Gendelman HE
Expert Opin Drug Deliv; 2017 Nov; 14(11):1281-1291. PubMed ID: 28128004
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology and the treatment of HIV infection.
Parboosing R; Maguire GE; Govender P; Kruger HG
Viruses; 2012 Apr; 4(4):488-520. PubMed ID: 22590683
[TBL] [Abstract][Full Text] [Related]
6. Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.
Guo D; Li T; McMillan J; Sajja BR; Puligujja P; Boska MD; Gendelman HE; Liu XM
Nanomedicine (Lond); 2014 Jul; 9(9):1341-52. PubMed ID: 23905578
[TBL] [Abstract][Full Text] [Related]
7. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
Khan T; Mayuresh Patkar M; Momin M; Omri A
Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicines for HIV therapy.
Siccardi M; Martin P; McDonald TO; Liptrott NJ; Giardiello M; Rannard S; Owen A
Ther Deliv; 2013 Feb; 4(2):153-6. PubMed ID: 23343155
[TBL] [Abstract][Full Text] [Related]
9. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
Wong HL; Chattopadhyay N; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
[TBL] [Abstract][Full Text] [Related]
11. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
Gupta U; Jain NK
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
[TBL] [Abstract][Full Text] [Related]
12. Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery.
Takalani F; Kumar P; Kondiah PPD; Choonara YE; Pillay V
Pharm Dev Technol; 2020 Mar; 25(3):267-280. PubMed ID: 31744408
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
Date AA; Destache CJ
Biomaterials; 2013 Aug; 34(26):6202-28. PubMed ID: 23726227
[TBL] [Abstract][Full Text] [Related]
15. Towards nanomedicines for neuroAIDS.
Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
[TBL] [Abstract][Full Text] [Related]
16. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.
Gunaseelan S; Gunaseelan K; Deshmukh M; Zhang X; Sinko PJ
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):518-31. PubMed ID: 19941919
[TBL] [Abstract][Full Text] [Related]
17. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.
Dash PK; Gendelman HE; Roy U; Balkundi S; Alnouti Y; Mosley RL; Gelbard HA; McMillan J; Gorantla S; Poluektova LY
AIDS; 2012 Nov; 26(17):2135-44. PubMed ID: 22824628
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles and Its Implications in HIV/AIDS Therapy.
Oti VB
Curr Drug Discov Technol; 2020; 17(4):448-456. PubMed ID: 31250759
[TBL] [Abstract][Full Text] [Related]
19. Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs.
Herskovitz J; Hasan M; Machhi J; Mukadam I; Ottemann BM; Hilaire JR; Woldstad C; McMillan J; Liu Y; Seravalli J; Sarella A; Gendelman HE; Kevadiya BD
Nanotheranostics; 2021; 5(4):417-430. PubMed ID: 33972918
[No Abstract] [Full Text] [Related]
20. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
Wu KY; Wang XC; Anderson M; Tran SD
Molecules; 2024 May; 29(10):. PubMed ID: 38792122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
